Deutsch   English   Français   Italiano  
<lbr238Fa73cU1@mid.individual.net>

View for Bookmarking (what is this?)
Look up another Usenet article

Path: ...!fu-berlin.de!uni-berlin.de!individual.net!not-for-mail
From: Bernard Peek <bap@shrdlu.com>
Newsgroups: rec.arts.sf.fandom
Subject: Re: Readercon code of conduct
Date: 30 May 2024 10:18:16 GMT
Lines: 44
Message-ID: <lbr238Fa73cU1@mid.individual.net>
References: <v2kkrb$15g4e$1@dont-email.me>
 <0001HW.2C03BE750045EC7470000856B38F@news.supernews.com>
 <6c70bb08-bf62-3bf8-1e39-25eca1609d63@example.net>
 <20240527172850.1573690f03e57af47ef1906f@127.0.0.1>
 <v32hvc$5ctc$1@dont-email.me>
X-Trace: individual.net Fe2ohmxTRof0b6G48u0xMA1K77qU9KNBYPatFN8/97setQ11Tb
Cancel-Lock: sha1:6rxS1p6xpvTm6wmgdyeiXrxWR9s= sha256:RVW5b1Vcgjhr7waebfGM/oORVLz7WxLtl4imWlb4COU=
User-Agent: slrn/1.0.3 (Linux)
Bytes: 2545

On 2024-05-27, Mike Van Pelt <usenet@mikevanpelt.com> wrote:
>
> What mRNA brings to the table is the ability to create a
> vaccine for a novel pathogen quickly, in weeks, rather than
> months or years.

The first candidate mRNA Covid vaccine took nine hours to produce.  Some of
the older vaccine technologies wouldn't have reached that stage for the best
part of a year.  The next problem to crack is speeding up testing.  The
safety of mRNA vaccines should help there too.


> This is so hugely valuable a technology that
> I was perfectly happy to be part of the large-scale trials.
> At 66, I was in the "starting to be at risk" population for
> COVID.  Two Moderna shots, and every booster that was offered.
> I have never gotten COVID, unless it was asymptomatic or one
> of those "minor cold" things I've gotten once or twice since
> the pandemic.  When I did take a COVID test, it was negative.
>
> If something much worse than COVID comes along (like MERS
> or SARS cutting loose) we will be very glad the tech exists.

We were lucky with Covid, the mortality rate was no higher than 0.5% at any
point. Spanish flu was more dangerous at about 2.5%. 

On the other hand it has given a lot of people a false sense of
security. There are some interesting parallels with the Y2K problem. 

>
> Still, I can see some justification for considering the shot
> *slightly* on the experimental side, and am uneasy about the
> draconian mandates.
>
The measures were probably excessive for a disease with a mortality of 0.5%
but would have been woefully inadequate if it had been 2.5% instead. We took
months to impose pretty feeble restrictions. I would like to see
response-times measured in hours.


-- 
Bernard Peek
bap@shrdlu.com
Wigan